Skip to main content

Advertisement

SpringerLink
Log in

Membrane alterations in health and disease with particular reference to immune function and cancer

  • Invited Paper
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Ever since the early microscopists and experimental biologists distinguished the fundamental differences between the animal and plant cells, investigations on the structure and function of the cell membrane have become a fascinating field of biomedical research. The membranes of all types of cells provide the biological border, and maintain the integrity of the cell by protecting it from toxic insult rendered by chemicals, biochemicals, toxins etc. The toxic damage of the cell membrane results in an alteration of the transport mechanism or transmits a message for altered DNA, RNA and protein synthesis, vis-a-vis altered cell division which ultimately leads to death of the cell. In fact, the ligand receptor binding, with particular reference to toxicants of different kinds, may alter the normal physiological function of the cell. If the damaged cell is involved in immune function, the host becomes more susceptible to infection. Prolonged immunosuppression may predispose the host to develop cancer, although cancer cells themselves originate as a result of genetic damage caused by environmental toxicants, endocytosed after binding with membrane receptors, finally reaching the genomic material to cause carcinogenic alteration. The phenomena of membrane binding, transmission of message., processing of message and eventual alteration of biomolecular structure consequently resulting in a disorder or disease process are described in the present communication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ray PK: Immune System — A unique device to protect the In: PK Ray (ed) Immunobiology of Transplantation, Cancer and Pregnancy. Pergamon Press, 1983 p 3–24

  2. Lehninger AL: Biochemistry. Kalyani Publications, Indian edition, 1978 p 279–305

  3. Connel ND and Romano AH: D-glucose transport by membrane vesicle from quiescent and SV 40 transformed mouse 3T3 cell. Biochem biophys Acta 729: 229–233, 1983

    Google Scholar 

  4. Moscatelli D and Rifkin DB: Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochem biophys Acta 948: 67–85, 1988

    Google Scholar 

  5. Weinstein IB: The origins of human cancer: Molecular mechanism of carcinogenesis and their implications for cancer prevention and treatment — Twenty seventh GHA Clowes Memorial award lecture. Cancer Res 48: 4135–4143,1988

    Google Scholar 

  6. Ray PK and Prasad AK: Tumor immunology. In: GP Talwar (ed) Text Book and Biotechnology (in press), 1989

  7. Knox P: The plasma membrane. Biologist 30:159–162,1983

    Google Scholar 

  8. Finean JB, Coleman R and Michell RH: Membranes and their cellular function. Blackwell Scientific Publications, 1978, p 132

  9. Singer J and Nicolson GL: The fluid mosaic model of the structure of membranes. Science 175: 720–731, 1972

    Google Scholar 

  10. Hokin LE: Receptors and phosphoinositide generated second messengers. Ann Rev Biochem 54: 205–235, 1985

    Google Scholar 

  11. Berridge MJ and Irvine RF: Inositol triphosphate. A novel second messenger in cellular transduction. Nature 312: 315–321,1984

    Google Scholar 

  12. Nizhizuka Y: The role of protein Kinase C in cell surface signal transduction and tumor promotion. Nature 308: 693–698,1984

    Google Scholar 

  13. Berridge MJ: Inositol 1,4,5-tri-phosphate and diacyl glycerol as second messengers. Biochem J 220: 345–360, 1984

    Google Scholar 

  14. Gomperts BD: Calcium and cellular activation. In: D Chapman (ed) Biological Membranes. Academic Press, London, 1984, p 289–348

    Google Scholar 

  15. Gupta RK and Morton DL: Tumor antigens. In: Immunobiology of Transplantation Cancer and Pregnancy. Pergamon Press, 1983, p 113–147

  16. Griffin GE and Pasternak CA: The cell surface and disease. Clinical Science 63: 1–9, 1982

    Google Scholar 

  17. Simmons RL, Lipschultz ML, Rios A and Ray PK: Failure of neuraminidase to unmask histo-compatibility antigens on trophoblast. Nature 231: 111–112, 1971

    Google Scholar 

  18. Ray PK: Bacterial neuraminidase and altered immunological behaviour of treated mammalian cells. In: Perlman D (ed) Advances in Applied Microbiology. Academic Press, New York, 1977, p 227–267

    Google Scholar 

  19. Chatterjee S and Ray PK: Pinocytic ability of neuraminidase treated amoeba. Indian J Exp Biol 13: 294–295, 1975

    Google Scholar 

  20. Chatterjee S, Seshadri M and Ray PK: Cell cycle dependent binding of radiolabelled Concanavalin A by amoeba. Indian J Exp Biol 17(8): 847–848, 1979

    Google Scholar 

  21. Ray PK and Seshadri M: Influence of parity status of female mice on growth of a transplantable chemically induced fibrosarcoma. Indian J Exp Biol 19: 405–407, 1981

    Google Scholar 

  22. Ray PK and Seshadri M: Effect of immunization of mice with syngeneic embryos on their ability to inhibit the growth of a challenging fibrosarcoma. Indian J Exp Biol 18: 1027–1029,1980

    Google Scholar 

  23. Simmons RL, Rios A and Ray PK: Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nature New Biol 231: 179–180, 1971

    Google Scholar 

  24. Ray PK, Gewurz H and Simmons RL: The mechanism of increased sensitivity of neuraminidase treated cells to antibody induced cytolysis. Fed Proc 29: 573–576, 1970

    Google Scholar 

  25. Ray PK and Simmons RL: Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells. Clin and Exp Immuno 10: 139–145, 1972

    Google Scholar 

  26. Ray P, Thakur VS and Sundaram K: Antitumor immunity. Differential response to neuraminidase treated and Xirradiated tumor vaccine. Eur J Cancer 11: 1–11, 1975

    Google Scholar 

  27. Ray PK and Seshadri M: Inhibition of growth of rat Yoshida Sarcoma using neuraminidase treated tumor vaccine. Indian J Exp Biol 17: 36–39, 1979

    Google Scholar 

  28. Simmons RL, Rios A, Ray PK and Lundgren G: Effect of neuraminidase on the growth of 3-methylcholantherene induced fibrosarcoma in normal and immunosuppressed syngeneic mice. JNCI 47(5): 1087–1096, 1971

    Google Scholar 

  29. Ray PK and Raychaudhuri S: Immunotherapy of Cancer-Present status and future trends. In: PK Ray (cd) Immunobiology of Transplantation Cancer and Pregnancy. Pergamon Press, 1983, p 210–239

  30. Ray PK: Immunosuppressor control as modality of cancer treatment: Effect of plasma adsorption withStaphylococcus aureus Protein A. In: FA Salinas (cd) Contemporary Topics in Immunology vol 15, Plenum Press, 1984, p 147–211

  31. Poduval TB, Seshadri M, Ray PK, Thakur VS and Sundaram K: Effect of host sensitization to tumor on splenic depletion and recovery following severe immunosuppressive treatment. Indian J Exp Biol 17: 1064–1967, 1979

    Google Scholar 

  32. Ray PK: Suppressor control as modality of cancer treatment: Perspectives and prospects in the immunotherapy of malignant disease. Plasma Ther 39(3): 101–121, 1982

    Google Scholar 

  33. Raychaudhuri S, Ray PK, Bassett JG and Cooper DR: High dose antigen induced suppressor generation in normal and tumor-bearing hosts. Fed Am Soc Exp Biol 39(3): 696–700,1980

    Google Scholar 

  34. Sjogren JO, Hellstrom I and Bansal SC: Suggestive evidence that the blocking antibodies of tumor bearing individuals may be antigen-antibody complexes. Proc Natl Acad Sci 63:1372–1375, 1978

    Google Scholar 

  35. Gershon RK, Mokyr MB and Mitchell MS: Activation of suppressor T cells by tumor cells and specific antibody. Nature 250: 594–596, 1974

    Google Scholar 

  36. Ray PK, Cooper DR, Bassett JG and Mark R: Antitumor effect of Staphylococcus aureus organism. Fed Proc 38: 4553–4558,1979

    Google Scholar 

  37. Ray PK and Bandyophadhyay SK: Inhibition of rat mammary tumor growth by purified Protein A. - A potential antitumor agent. Immunol Commun 12: 453–464, 1983

    Google Scholar 

  38. Prasad AK, Singh KP, Saxena AK, Mathur N and Ray PK: Increased macrophage activity in Protein A treated tumor regressed animals. Immunopharmacol and Immunotoxicol 9: 451–561, 1987

    Google Scholar 

  39. Ray PK, Clark L and Mc Laughlin D: Immunotherapy of cancer: extracorporeal adsorption of plasma-blocking factors using non-viableStaphylococcus aureus Cowan 1. In: Beyer JH, Borberg H, Fuchs CH, Nagel GA (eds) Plasmapheresis in immunology and oncology. Basel: S Karger, 1982, p 102–113

    Google Scholar 

  40. Ray PK, Mohammed J, Allen P, Raychaudhuri S, Dohadwala M, Bandyopadhyay S and Mark R: Effect of frequency of plasma adsorption over Protein A — containingStaphylococcus aureus on regression of rat mammary adenocarcinomas: Modification of antitumor immune response and tumor histopathology. J Biol Resp Modif 3(1): 39–58, 1984

    Google Scholar 

  41. Ray PK, Thakur VS and Sundaram K: Antitumor immunity II viability, tumorigenicity and immunogenicity of neuraminidase treated tumor cells: Effective immunization of animals with a tumor vaccine. J Natl Cancer Inst 56(1): 83–94, 1976

    Google Scholar 

  42. Weiss L: J Cell Biol 26: 735–741, 1965

    Google Scholar 

  43. Schmidtke JR, Hoffman R, Grage TB, Ray PK and Simmons RL: Effect of neuraminidase on the phagocytosis of heterologous red cells. J Reticuloendothelial Soc. 13: 360–376,1973

    Google Scholar 

  44. Ray PK, Gewurz H and Simmons RL: The serologic behaviour of neuraminidase — treated lymphoid cell: Alloantigenicity and complement sensitivity. Clin Exp Immunol 11: 441–455,1972

    Google Scholar 

  45. Lundgren G and Simmons RL: Effect of neuraminidase on stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol 9: 915–920, 1971

    Google Scholar 

  46. Ray PK, Gewurz H and Simmons RL: Complement sensitivity of neuraminidase treated lymphoid cells. Transplantation 12: 327–330, 1971

    Google Scholar 

  47. Rosenberg SA, Plocinik BA and Rogentine GN: Unmasking of human lymphoid cell heteroantigens by neuraminidase treatment. JNCI 48: 1271–1275, 1972

    Google Scholar 

  48. Pensky J and Schwick HG: Human serum inhibitor of Cl'esterase: Identity with α2-neura-minoglycoprotein. Science 163:698–699,1969

    Google Scholar 

  49. Cowan FM, Klein DL, Armstrong GR and Pearson JW: Augmentation and inhibition of delayed hypersensitivity byStaphylococcus aureus Protein A. Biomedicine 30: 241–246,1979

    Google Scholar 

  50. Kronwall G and Williams RA Jr: Differences in anti-protein A activity among IgG subgroups. J Immunol 103: 828–832,1969

    Google Scholar 

  51. Kerbel RA and Davies AJS: The possible biological significance of Fc receptor on mammalian lymphocytes and tumor cells. Cell 3: 105–112, 1974

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Industrial Toxicology Research Centre, M. G. Marg Lucknow-226 001, P. O. Box-80, (U. P.), India

    P. K. Ray & A. K. Prasad

Authors
  1. P. K. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. K. Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ray, P.K., Prasad, A.K. Membrane alterations in health and disease with particular reference to immune function and cancer. Mol Cell Biochem 91, 13–21 (1989). https://doi.org/10.1007/BF00228074

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00228074

Key words

Search

Navigation